口服羟氯喹致唇黏膜色素沉着三例

doi:10.12144/zgmfskin202407484

Abstract

Abstract: Hydroxychloroquine（HCQ） is a drug widely used to treat malaria and autoimmune diseases, and has recently been used to treat rosacea and could be promoted for use in female patients due to its pregnancy safety. Three cases of lip mucosal hyperpigmentation after oral hydroxychloroquine administration in patients with rosacea is reported, with no adverse effects other than hyperpigmentation, and relief of rosacea lesions after treatment. After discontinuing hydroxychloroquine, a patient' lip mucosal hyperpigmentation slightly decreased.

Key words: rosacea')">">rosacea, hydroxychloroquin, lip mucosal, hyperpigmentation

LYU Shuang, FU Xi'an, SHI Zhongxiang, YUE Zhenhua, ZHANG Huimin, LIU Hong, ZHANG Furen. Hydroxychloroquine induced lip mucosal hyperpigmentation: three cases report[J].China Journal of Leprosy and Skin Diseases, 2024, 40(7): 484-487.

0
/ / Recommend rosacea; hydroxychloroquin; lip mucosal; hyperpigmentation”. Please open it by linking:http://www.zgmfskin.com/EN/abstract/abstract12328.shtml" name="neirong"> rosacea; hydroxychloroquin; lip mucosal; hyperpigmentation">

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://www.zgmfskin.com/EN/10.12144/zgmfskin202407484

http://www.zgmfskin.com/EN/Y2024/V40/I7/484

[1]	HUAI Pengcheng, CHU Tongsheng, LIU Dianchang, LIU Jian, ZHANG Furen. Analysis of factors for delayed detection of 3 leprosy cases with disability [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(7): 488-490.
[2]	LI Dan, YANG Guangshu, XU Xia. Survey on the situation of leprosarium in Guangyuan and integration method exploration [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(7): 491-493.
[3]	MI Qian, MENG Zhaoying, YANG Jinliang. Clinical amyopathic dermatomyositis with anti-MDA5 antibody positive: a case report and literature review [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(7): 494-498.
[4]	ZHU Li, ZHAO Qing, WANG Na, RAN Delin, YANG Baoqi, LIU Yongxia, LIU Hong, ZHANG Furen. Toxic epidermal necrolysis caused by osimertinib and literature review [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(6): 396-401.
[5]	CUI Yinling, XU Fanli, CAO Shan, XUE Xiaotong, ZHAO Qing, LIU Yongxia, LIU Hong, ZHANG Furen. Abrocitinib in the treatment of cutaneous lichen planus: two cases and literature review [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(6): 412-415.
[6]	ZHENG Chunzhi, ZHANG Minkuo, SAI Wenwen, CAO Yuanyuan, ZHANG Zhaoxia, PAN Futang, YANG Baoqi, LIU Hong. Bullous pemphigoid occurred after long-term treatment with camrelizumab in a patient with oesophageal cancer: a case report [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(6): 422-424.
[7]	WANG Jianwen, CHEN Xuechao, ZHOU Guizhi, CHEN Shengli, LU Xianmei, ZHANG Xueyan, ZHANG Fan, LIU Yongxia. Clinical and histopathological characters of 28 cases of subungual melanoma [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 182-185.
[8]	HAN Jinghong, LIU Hong. Two children with refractory atopic dermatitis successfully treated with Janus kinase inhibitors [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 190-192.
[9]	LU Yu, JIANG Dong, YANG Dengke, HU Siyuan, YUAN Dezheng, ZHOU Xiaomei, QIN Jianping, GE Jinhong, ZHANG Fengrui, LI Wenyao, GUO Yiyu. Adalimumab for the treatment of perifolliculitis capitis abscedens et suffodiens: a case report [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 210-211.
[10]	LIU Yan, LIU Mengmeng, LIU Yongxia, LU Xianmei, LIU Guoyan. Generalized fibrous hamartoma in infants: a case report [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 212-214.
[11]	XIONG Fei, CAO Jingjiang. Orf: a case report [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 214-215.
[12]	JIAO Yuzhu, YANG Qing. Update of treatment of pyoderma gangrenosum [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 216-220.
[13]	ZHANG Ying, NIU Xuping. Update of targeted treatment of pemphigus [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 221-224.
[14]	MAO Chong, XIONG Junhao. The past and present of leprosy treatment [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 225-228.
[15]	BI Zhaohua, XIE Kai, LIU Guoyan, CHEN Shengli, GUO Xuan. Mohs microsurgery in treatment of eccrine porocarcinoma [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(2): 113-115.

Hydroxychloroquine induced lip mucosal hyperpigmentation: three cases report

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Comments

Recommended 10